Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Arquivos Brasileiros De Cardiologia
|
April 25, 2014
Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release
Celso Kiyochi Takimura, Carlos Augusto Homem M Campos, Pedro Henrique Magualhães Craveiro Melo, et al.
Revista Da Associacao Medica Brasileira (1992)
|
March 24, 2016
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI
Vitor Emer Egypto Rosa, Antonio Sergio de Santis Andrade Lopes, Tarso Augusto Duenhas Accorsi, et al.
Lancet (London, England)
|
October 17, 2015
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
Michael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
European Heart Journal. Cardiovascular Imaging
|
December 28, 2018
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysis
Yuichi Ozaki, Hector M Garcia-Garcia, Alexandre Hideo-Kajita, et al.
Einstein (Sao Paulo, Brazil)
|
October 15, 2025
Inflammatory response to elective percutaneous coronary intervention is related to myocardial injury
Priscilla Teixeira Céo Frisso, Henrique Trombini Pinesi, Fernando Ramos de Mattos, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
August 8, 2021
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years
Michael Haude, Ralph Toelg, Pedro Alves Lemos, et al.
European Heart Journal
|
May 19, 2016
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Michael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
February 13, 2025
Right ventricular-pulmonary arterial coupling in schistosomiasis associated pulmonary arterial hypertension
Jose Leonidas Alves-Jr, Eduardo Leite Vieira Costa, Susana Hoette, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 13, 2016
Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study
Remo Holanda de Mendonça Furtado, Robert Patrick Giugliano, Celia Maria Cassaro Strunz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
October 24, 2020
Natural History of Adapted Leaman Score Assessing Coronary Artery Disease Progression by Computed Tomography Angiography: A 7-Year Follow-Up Report
Alexandre Hideo-Kajita, Hector M Garcia-Garcia, Rodrigo Rubarth, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Arquivos Brasileiros De Cardiologia
|
April 25, 2014
Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release
Celso Kiyochi Takimura, Carlos Augusto Homem M Campos, Pedro Henrique Magualhães Craveiro Melo, et al.
Revista Da Associacao Medica Brasileira (1992)
|
March 24, 2016
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI
Vitor Emer Egypto Rosa, Antonio Sergio de Santis Andrade Lopes, Tarso Augusto Duenhas Accorsi, et al.
Lancet (London, England)
|
October 17, 2015
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
Michael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
European Heart Journal. Cardiovascular Imaging
|
December 28, 2018
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysis
Yuichi Ozaki, Hector M Garcia-Garcia, Alexandre Hideo-Kajita, et al.
Einstein (Sao Paulo, Brazil)
|
October 15, 2025
Inflammatory response to elective percutaneous coronary intervention is related to myocardial injury
Priscilla Teixeira Céo Frisso, Henrique Trombini Pinesi, Fernando Ramos de Mattos, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
August 8, 2021
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years
Michael Haude, Ralph Toelg, Pedro Alves Lemos, et al.
European Heart Journal
|
May 19, 2016
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Michael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
February 13, 2025
Right ventricular-pulmonary arterial coupling in schistosomiasis associated pulmonary arterial hypertension
Jose Leonidas Alves-Jr, Eduardo Leite Vieira Costa, Susana Hoette, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 13, 2016
Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study
Remo Holanda de Mendonça Furtado, Robert Patrick Giugliano, Celia Maria Cassaro Strunz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
October 24, 2020
Natural History of Adapted Leaman Score Assessing Coronary Artery Disease Progression by Computed Tomography Angiography: A 7-Year Follow-Up Report
Alexandre Hideo-Kajita, Hector M Garcia-Garcia, Rodrigo Rubarth, et al.
Page
of 6